SCHEMBL3468263

SCHEMBL3468263

O=C(O)CCC1Cc2cc(-c3ccc(C(F)(F)F)cc3)ccc2NC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.53
TDP2 O95551 1/20 0.46
CDK2 P24941 2/20 0.39
AKT1 P31749 2/20 0.39
CDK1 P06493 1/20 0.39
KIT P10721 1/20 0.39
KDR P35968 1/20 0.39
DGAT1 O75907 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
KMT2A Q03164 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
CCKAR P32238 1/20 0.36
CCKBR P32239 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3308412 0.91 KIF11 (0.53) KIF11TDP2CDK2AKT1CDK1
SCHEMBL4891219 0.87 KIF11 (0.56) KIF11TDP2CDK2AKT1CDK1
SCHEMBL3467592 0.85 KIF11 (0.52) KIF11TDP2CDK2AKT1CDK1
SCHEMBL3468115 0.83 KIF11 (0.47) KIF11TDP2CDK2AKT1CDK1
SCHEMBL4594888 0.82 KIF11 (0.56) KIF11TDP2CDK2AKT1CDK1
SCHEMBL3467771 0.81 KIF11 (0.48) KIF11TDP2CDK2AKT1CDK1
SCHEMBL3467252 0.81 KIF11 (0.53) KIF11TDP2CDK2AKT1CDK1
SCHEMBL3467357 0.81 AKR1C3 (0.45) KIF11FFAR1PPARDPPARA
SCHEMBL3466969 0.81 S1PR5 (0.43) KIF11RXRARXRBRXRG
SCHEMBL3713898 0.81 KMT2A (0.43) KIF11TDP2DGAT1KMT2APPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010074807-A1 3, 4-DIHYDROQUINOLIN-2 ( 1H ) -ONE DERIVATIVES AS SODIUM CHANNEL MODULATORS GILEAD PALO ALTO, INC. (US) 2010-07-01 WO disclosed